GlassScriptPhysician profile
Barry S Weinstock
NPI 1548213200
$156,111.48
in general payments reported to CMS, 2019-2025
63 companies · $5,050 in 2025
The $5,050 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $82K · 2020: $25K · 2021: $14K · 2022: $6,780 · 2023: $4,339 · 2024: $19K · 2025: $5,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $8,102 · Honoraria: $6,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,822.09 |
| Travel and Lodging | $8,101.72 |
| Honoraria | $6,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $50,427.26 | 2019-2020 | |
| Penumbra, INC. | $18,611.16 | 2019-2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $16,475.68 | 2019-2024 | Eluvia, Varithena Administration Pack |
| Angiodynamics, INC. | $15,055.56 | 2019-2020 | |
| Medtronic, INC. | $8,371.72 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Symplicity G3 |
| Idev Technologies, INC. | $8,099.61 | 2020 | |
| Inari Medical, INC. | $7,536.43 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $6,555.86 | 2019-2025 | Impella |
| Abbott Laboratories | $5,465.53 | 2019-2025 | Aveir, Cardiomems, Mitraclip |
| Biotronik INC. | $4,490.01 | 2019-2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Cvrx, INC. | $3,441.91 | 2019-2025 | Barostim Neo System |
| Stryker Corporation | $2,018.75 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $1,651.60 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Siemens Medical Solutions USA, INC. | $858.58 | 2019-2021 | |
| Terumo Medical Corporation | $651.75 | 2019 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $572.92 | 2019-2022 | |
| Intact Vascular, INC. | $511.56 | 2019 | |
| Amgen INC. | $497.02 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $339.20 | 2020-2025 | |
| Cardiovascular Systems INC. | $331.96 | 2019-2023 | Diamondback Peripheral |
| Impulse Dynamics (USA) INC. | $278.74 | 2021-2022 | |
| Pfizer INC. | $273.44 | 2021-2025 | |
| Zoll Respicardia, INC. | $239.37 | 2021 | |
| Cook Medical LLC | $236.38 | 2019-2020 | |
| Celonova Biosciences, INC. | $221.50 | 2019-2021 | |
| Cardiva Medical, INC. | $196.75 | 2024-2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Imperative Care, INC | $191.32 | 2024 | Symphony Catheter, Prodigy Catheter |
| Janssen Pharmaceuticals, INC | $170.99 | 2019-2023 | Xarelto |
| Teleflex LLC | $170.90 | 2019-2025 | Guideliner, Turnpike |
| Kestra Medical Technology Services, INC. | $170.19 | 2024 | Assure Wcd |
| Thrombolex, INC. | $159.90 | 2023 | Bashir .035 Endovascular Catheter, Bashir S-B .035 Endovascular Catheter |
| Inspiremd LTD | $159.12 | 2025 | Cguard Prime Carotid Stent System |
| Limflow INC. | $155.66 | 2023 | Limflow System |
| Contego Medical, INC | $140.00 | 2024 | |
| Venclose INC. | $125.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.50 | 2019-2022 | |
| Amarin Pharma, INC. | $116.37 | 2019-2022 | |
| United Therapeutics Corporation | $110.00 | 2021 | |
| Esperion Therapeutics, INC. | $104.12 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $100.95 | 2020-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.88 | 2020-2024 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $84.48 | 2019 | |
| Sanofi-Aventis U.S. LLC | $81.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $80.76 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Corindus INC. | $69.89 | 2019 | |
| Nuwellis, INC. | $46.13 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.84 | 2021 | |
| Edwards Lifesciences Corporation | $24.58 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.54 | 2025 | Wainua |
| Atricure, INC. | $22.53 | 2024 | |
| Akcea Therapeutics, INC. | $20.67 | 2020 | |
| Braemar Manufacturing, LLC | $19.37 | 2019 | |
| Wright Medical Technology, INC. | $18.63 | 2019 | |
| Cashflow Solutions, LLC | $15.48 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Avantec Vascular Corporation | $15.45 | 2021 | |
| Organogenesis INC. | $14.15 | 2021 | |
| Zoll Circulation INC | $13.44 | 2021 | |
| Livanova USA, INC. | $13.08 | 2021 | |
| Cardinal Health 200 LLC | $11.74 | 2019 | |
| Tactile Systems Technology INC | $10.85 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$107,323.90 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Weinstock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.